GEOapplication/xmlftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE312nnn/GSE312124/primaryOK200TranscriptomicsHomo sapiensExpression profiling by high throughput sequencinghttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312124GEOGSEfalseMAPK- driven glioma progression and reprogramming of the tumor-associated immune responseGlioma evolution is associated with disease progression and therapeutic resistance. We recently identified a group of MAPK-driven glioma with CDKN2A homozygous deletion that are low-grade and immune enriched. However, Over time, these tumors can progress to aggressive, higher-grade tumors. While low-grade tumors may be amenable to immunotherapeutic strategies, it is unknown how the tumor and its microenvironment evolve.2026/07/16GSE312124GSM9338107GSM9338108GSM9338103GSM9338104GSM9338105GSM9338106GSM9338099GSM9338100GSM9338101GSM933810224676312124Homo sapiens[42377256]